CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.997
EU - Europa 8.088
AS - Asia 5.392
SA - Sud America 670
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 236
OC - Oceania 34
Totale 23.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.810
RU - Federazione Russa 2.820
SG - Singapore 1.934
CN - Cina 1.736
IT - Italia 1.656
GB - Regno Unito 1.280
BR - Brasile 526
SE - Svezia 448
VN - Vietnam 437
FR - Francia 423
HK - Hong Kong 406
DE - Germania 349
IE - Irlanda 305
FI - Finlandia 296
KR - Corea 183
IN - India 138
BD - Bangladesh 120
CA - Canada 106
NL - Olanda 102
EG - Egitto 75
UA - Ucraina 75
TR - Turchia 71
JP - Giappone 58
ID - Indonesia 51
ES - Italia 49
BE - Belgio 47
AR - Argentina 46
PL - Polonia 46
PK - Pakistan 43
ZA - Sudafrica 40
AT - Austria 38
MX - Messico 37
CH - Svizzera 35
IR - Iran 34
AU - Australia 31
NG - Nigeria 31
IQ - Iraq 30
SA - Arabia Saudita 27
CL - Cile 23
EC - Ecuador 23
CZ - Repubblica Ceca 19
MA - Marocco 16
CO - Colombia 15
JO - Giordania 15
UZ - Uzbekistan 15
BJ - Benin 13
VE - Venezuela 13
GR - Grecia 12
PY - Paraguay 12
TG - Togo 12
IL - Israele 11
MK - Macedonia 11
JM - Giamaica 10
PH - Filippine 10
NO - Norvegia 9
OM - Oman 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
DK - Danimarca 8
LV - Lettonia 8
MY - Malesia 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
EU - Europa 7
HU - Ungheria 7
LT - Lituania 7
DO - Repubblica Dominicana 6
KE - Kenya 6
PT - Portogallo 6
DZ - Algeria 5
NP - Nepal 5
PE - Perù 5
SD - Sudan 5
CI - Costa d'Avorio 4
PA - Panama 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
ML - Mali 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
CG - Congo 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
Totale 23.385
Salva come PNG Salva come JPEG
Città #
Ashburn 1.168
Dallas 1.069
Moscow 994
Southend 987
Singapore 973
Chandler 786
San Jose 747
Hong Kong 392
Woodbridge 382
Verona 376
Ann Arbor 374
Jacksonville 333
Council Bluffs 331
Beijing 325
Dublin 306
New York 243
The Dalles 234
Houston 165
Los Angeles 158
Wilmington 126
Lawrence 122
Princeton 122
Ho Chi Minh City 120
Helsinki 114
Milan 114
Jinan 110
Nanjing 103
Hebei 88
Shenyang 88
Hanoi 84
Buffalo 82
Santa Clara 79
Munich 77
Boardman 73
Redondo Beach 62
Columbus 61
São Paulo 59
Washington 58
Rome 56
Orem 54
Tianjin 52
Zhengzhou 47
Tokyo 46
Montreal 45
Changsha 44
Lancaster 44
Brussels 43
Dong Ket 43
London 42
Redwood City 42
Hangzhou 40
Ningbo 40
Turku 40
Cairo 38
Chennai 38
Warsaw 38
Haikou 37
Nanchang 37
Amsterdam 35
Jakarta 35
Redmond 35
Seattle 35
Guangzhou 34
Bologna 32
Atlanta 31
Johannesburg 31
Taiyuan 30
Istanbul 28
Phoenix 28
Seoul 28
Sindelfingen 28
Taizhou 28
Naples 26
Boston 25
Abuja 24
Brooklyn 24
Denver 24
Stockholm 23
Chicago 22
Frankfurt am Main 22
Fuzhou 21
Catania 20
Da Nang 20
Dearborn 20
Falls Church 20
Paris 20
Tehran 20
Jiaxing 19
Shanghai 19
Toronto 19
Norwalk 18
Nuremberg 18
Padova 18
Poplar 18
Vienna 18
Lappeenranta 17
Mexico City 17
Haiphong 16
Manchester 16
Mumbai 16
Totale 13.949
Salva come PNG Salva come JPEG
Nome #
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 644
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 457
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 352
The effectiveness of combining a home-based Digital motor Telerehabilitation program with conventional therapy in progressive multiple sclerosis: A study protocol for a multicenter, randomized controlled trial 334
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 306
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 283
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 274
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 264
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 263
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 240
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 236
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 234
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 232
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 229
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 228
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 224
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 224
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 223
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 221
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 220
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 219
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 218
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 216
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 215
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 215
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 214
A case of acute fulminant multiple sclerosis treated with alemtuzumab 214
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 213
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 212
Cognitive onset in multiple sclerosis 210
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 210
Brentuximab vedotin: axonal microtubule's Apollyon 210
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 209
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 208
Risk factors for post-polio syndrome among an Italian population: a case-control study. 207
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 206
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 206
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 204
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 196
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 195
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 193
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 190
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 188
Amyloid myopathy: an intriguing diagnosis 187
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 186
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 186
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 186
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 184
Epilepsy in multiple sclerosis: The role of temporal lobe damage 184
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 181
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 181
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 179
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 178
Response to Nagai et al. 177
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 176
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 175
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 174
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 173
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 171
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 171
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 170
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 166
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 164
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 164
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 163
Promoting participatory research in chronicity: The ESPRIMO biopsychosocial intervention for young adults with multiple sclerosis 162
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 160
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 160
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 157
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 157
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 155
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 154
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 151
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 150
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 150
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 149
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 148
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 148
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 148
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 146
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 145
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 145
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 144
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 143
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 142
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 141
Long survival and clinical stability in Marburg's variant multiple sclerosis. 141
HCV-related nervous system disorders. 140
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 140
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 138
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 135
Prognostic factors of acute partial transverse myelitis. 133
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 131
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 130
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 129
Ofatumumab for relapsing forms of multiple sclerosis 129
Switching multiple sclerosis patients with breakthrough disease to second-line therapy. 128
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 128
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 127
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 126
Totale 19.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.177
article - articoli 73.471
book - libri 0
conference - conferenze 2.771
curatela - curatele 0
other - altro 577
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.358
Totale 156.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.079 0 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20253.312 169 200 201 486 174 148 188 178 478 246 274 570
2025/202610.224 680 484 1.092 1.534 2.521 610 863 490 850 580 247 273
2026/2027361 133 228 0 0 0 0 0 0 0 0 0 0
Totale 23.658